TZ Limited announces acquisition of Keyvision to boost proptech capabilities

Pallavi Madhiraju- October 21, 2024

TZ Limited, a leader in smart locker solutions, has announced a strategic acquisition aimed at expanding its proptech capabilities. The company entered a Heads of ... Read More

Noble Helium secures multi-million-dollar funding—what does it mean for investors?

Pallavi Madhiraju- October 19, 2024

Noble Helium Limited (ASX) has entered into an At-The-Market (ATM) subscription agreement with Dolphin Corporate Investments (DCI), enabling the company to access up to A$2 ... Read More

InhaleRx secures A$38.5m deal to accelerate pain and mental health breakthroughs

Pallavi Madhiraju- October 19, 2024

Melbourne-based healthcare innovator InhaleRx Limited (ASX: IRX) has secured a substantial funding deal worth up to AUD 38.5 million, aiming to revolutionize the treatment of ... Read More

Dubber Corporation launches A$25m equity raising to secure growth ambitions

Pallavi Madhiraju- October 11, 2024

In a significant financial move, Dubber Corporation Limited has announced a A$25 million equity raising, fully underwritten to secure the company's growth trajectory and fuel ... Read More

Neuren Pharmaceuticals advances NNZ-2591 for Phelan-McDermid syndrome to Phase 3 clinical trial

Pallavi Madhiraju- October 7, 2024

Neuren Pharmaceuticals has secured approval from the United States Food and Drug Administration (FDA) to progress into the first-ever pivotal Phase 3 clinical trial of ... Read More

Immuron Limited reveals key findings from NMRC study, eyes future collaboration with U.S. DoD

Pallavi Madhiraju- October 6, 2024

Immuron Limited has announced the results of a Campylobacter human infection model study conducted by the U.S. Naval Medical Research Command (NMRC). The Melbourne-based biopharmaceutical ... Read More

Clinuvel Pharmaceuticals submits NDA for SCENESSE to Health Canada, aiming to treat rare genetic disorder

Pallavi Madhiraju- October 1, 2024

Clinuvel Pharmaceuticals has filed a New Drug Submission to Health Canada for its innovative therapy, SCENESSE, marking a potential breakthrough for Canadian patients suffering from ... Read More

Philips to distribute 4DMedical’s cutting-edge lung health technology across U.S.

Pallavi Madhiraju- September 29, 2024

In a monumental move set to shake up the U.S. healthcare industry, 4DMedical has just announced a comprehensive distribution agreement with global healthcare giant Philips. ... Read More

Pharma breakthrough! BioIntelect to revolutionise trials using Opyl’s cutting-edge tech

Pallavi Madhiraju- September 25, 2024

In a landmark collaboration, Opyl Limited announced a new six-month agreement with BioIntelect, a renowned Clinical Research Organisation (CRO) and strategic consulting firm in the ... Read More

Firstsource Solutions expands into Australia and New Zealand, creating 400 jobs in Victoria

Pallavi Madhiraju- September 19, 2024

In a bold move reflecting its ambitious global growth strategy, Firstsource Solutions Limited, part of the RP-Sanjiv Goenka Group, has officially launched operations in Australia ... Read More